Drug Type Small molecule drug |
Synonyms MC-1101 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2/3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
dry age-related macular degeneration | Phase 3 | United States | 01 Apr 2014 | |
Dystrophy, Macular | Phase 3 | United States | - | |
Dystrophy, Macular | Phase 3 | Taiwan Province | - | |
Dystrophy, Macular | Phase 3 | Taiwan Province | - | |
Geographic Atrophy | Phase 1 | United States | 01 Sep 2013 | |
Early onset of age-related macular degeneration | Phase 1 | United States | 01 Aug 2009 |